Clinical Trial Update: Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial evaluating Vitamin D3 (cholecalciferol) for systemic lupus erythematosus has terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: TERMINATED | Results posted: 2015-12-03